10 ml of Semaglutide: What the Measurement Actually Tells You

Where the "10 ml" figure comes from, and why it rarely applies to Wegovy patients

When researchers and pharmacists discuss semaglutide in volume terms, they are describing the bulk liquid in which the active molecule is dissolved. A 10 ml vial of semaglutide, for example, is a format used in clinical trial dispensing and, in some countries, by compounding pharmacies that mix the drug themselves. The STEP 1 trial, published in the New England Journal of Medicine and involving 1,961 adults with obesity, used subcutaneous injections of semaglutide 2.4 mg once weekly and reported an average body-weight reduction of around 15 per cent over 68 weeks. None of those participants was drawing 10 ml from a vial; they received pre-measured doses. That distinction matters, because the volume-in-a-vial framing belongs to a supply-chain or research context, not to everyday treatment.

In the UK, Wegovy is approved by the MHRA as a pre-filled, once-weekly injection pen. The pen delivers a fixed milligram dose, you do not measure, you simply inject after attaching a needle. If you have seen "10 ml semaglutide" on a website offering vials or powder for reconstitution, that product is not the same as the licensed medicine dispensed by a regulated UK pharmacy. The Wegovy overview on our site walks through exactly what the licensed format looks like and how the pen is used.

The NHS medicines page for semaglutide describes the approved dosing pathway in plain terms, which is a reliable starting point if you want to understand what a legitimate prescription involves.

What 10 ml of semaglutide would actually contain, and the licensing context behind it

To put a number on it: Wegovy's 2.4 mg maintenance pen contains 0.75 ml of solution. A 10 ml container of semaglutide at a typical concentration used in trials (roughly 1.34 mg per ml) would hold around 13–14 mg of the active drug, enough for many weeks of treatment at various dose steps. That kind of container is relevant to a hospital pharmacy or a clinical trial site. It is not a format available through standard UK licensed channels, and it is not something a patient would administer at home.

This matters for safety reasons. The MHRA has issued repeated warnings about unlicensed semaglutide products circulating online, including vials labelled for "research use" that have been sold as if they were equivalent to the licensed medicine. They are not. Concentration, sterility, excipient composition and stability are verified in the licensed product through the full regulatory process; none of that applies to a vial purchased from an unverified source. Our semaglutide information page covers the safety background in more detail, including how to check whether a pharmacy is GPhC-registered before you order anything.

For anyone curious about how different dose volumes compare at earlier points in the titration schedule, the 1 ml semaglutide page and the 2 ml semaglutide page explore similar volume questions at those scales.

What the licensed UK dose steps look like, and who decides them

Wegovy's dose escalation is measured in milligrams, not millilitres. Treatment begins at 0.25 mg once weekly, stepping up approximately every four weeks through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg. The MHRA approved a higher 7.2 mg maintenance dose in January 2026, and a dedicated single-dose 7.2 mg pen followed in April 2026. Across those steps, the volume of liquid injected per dose is small, under 1 ml at every stage. That is a long way from 10 ml of semaglutide.

The prescriber decides the pace of titration based on how you are tolerating each dose. Pushing through too quickly is one of the main reasons people experience more nausea than necessary. At nume, a GPhC-registered independent prescriber reads every consultation personally and reviews each repeat before anything is dispatched. It is worth checking what the semaglutide 10 mg page covers if you have been reading about higher-dose products, since that page addresses a different but related point of confusion.

If cost is a question alongside how dosing works, Wegovy pricing in the UK sets out what the current private-prescription landscape looks like, worth reading before comparing providers. For a broader look at what weight-loss treatment options are available through a regulated pharmacy, the weight management overview is a good place to start. And if you are already on another medicine and want to understand interactions, our page on semaglutide and lithium is one example of the clinical interaction questions our prescribers field regularly.

Practical storage and what to do once you have a legitimate prescription

Licensed Wegovy pens are refrigerated between 2 °C and 8 °C until you are ready to use them, the fridge door is fine, as long as it is not near the freezer compartment. Once you have started a pen, keep it in the fridge between doses; your Patient Information Leaflet gives the exact room-temperature window if you ever need to travel without a cool bag. This is a detail worth reading carefully because it differs slightly from the guidance people sometimes find for compounded or unlicensed versions online.

If you would like to find out whether Wegovy is clinically appropriate for you, a good first step is speaking with a prescriber rather than working backwards from volume measurements. At our pharmacy, consultations are free, clinical review happens the same day, and any treatment approved before midday on a weekday is dispatched that afternoon by DPD in plain packaging. Our clinical team can answer questions about how the titration schedule works for your specific circumstances. You can also browse frequently asked questions before you start. When you are ready, check your eligibility and one of our prescribers will take it from there.